Accelerating Time to Market for CAR-T Cell Therapies through Translatable Workflow

To view the webinar, please login to your account.

No account yet? Register.

Watch this 60-min roundtable discussion and join our expert panel as they discuss challenges, promising tools, trends and the future of CAR-T therapies.

Don't have time to watch the full webinar? Just click the blue arrow next to the video and access the written summary. 

Topics include:

• Key considerations for advancing CAR/TCR therapies to the clinic and commercialization
• Major pain points in CAR-T processes that need further development
• Advantages and challenges of closed system transduction/transfection platforms
• Selecting raw materials and GMP ancillary choices
• The future of CRISPR/CAS based systems

Panelists:

• Isabelle Rivière
  Director, Cell Therapy and Cell Engineering Facility, Memorial Sloan Kettering Cancer Center
• Metin Kurtoglu
  Chief GMP Manufacturing and Chief Medical Officer, Cartesian Therapeutics
• Tariq Haq
  Head of Cell and Gene Therapy Segment Marketing at Lonza Bioscience Solutions

This event has been produced in collaboration with BioInsights.

Would you like to learn more about Lonza’s integrated, scalable solutions for CAR-T and cell and gene therapy development and manufacturing?

Would you like to receive updates? Subscribe to our cell and gene therapy eNews to stay tuned on new educational content or product and applications news.